0 avis
Long‐term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I
Archive ouverte
International audience. Abstract: Interferon has been shown to be an effective treatment of congenital dyserythropoiesis type I (CDA‐I), but the optimal dose and the feasibility of this treatment remains to be determined. Here, in a 9‐yr follow‐up of a single patient, we show that interferon remains active during such a long period. The optimal dose of conventional alpha interferon could be evaluated at 2 million units twice a week. Pegylated interferon could be used as well at a dose of 30 μ g/wk. During interferon treatment, serum and erythrocyte ferritin levels decreased progressively, and remained inversely correlated with haemoglobin levels. On repeated liver biopsies, iron overload could be normalized. Low dose interferon is a long‐term treatment of CDA‐I, and allows a significant decrease in iron overload, that could be interesting even in patients who are only moderately anaemic.
Consulter en ligne
Suggestions
Du même auteur
